Table 2.
Clinical response | (95% CI) | |
---|---|---|
Overall response rate | 27 | 90% (76–95%) |
CR/CRu | 23 | 77% (63–90%) |
PR | 4 | 13% (5–30%) |
PD | 3† | 10% (3–26%) |
All three patients with PD had leukaemic presentations of MCL.
CR/CRu, complete response/unconfirmed CR; PR, partial response; PD, progressive disease